Protease-Activated Receptor-2 Activation Causes EDHF-Like Coronary Vasodilation
- 8 March 2002
- journal article
- other
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 90 (4) , 465-472
- https://doi.org/10.1161/hh0402.105372
Abstract
Activation of protease-activated receptor (PAR)-2 has been proposed to be protective in myocardial ischemia/reperfusion (I/R) injury, an effect possibly related to an action on the coronary vasculature. Therefore, we investigated the effects of PAR2 activation on coronary tone in isolated perfused rat hearts and elucidated the mechanisms of any observed effects. Although having a negligible effect on ventricular contractility, the PAR2 activating peptide SLIGRL produced an endothelium-dependent coronary vasodilatation (ED50=3.5 nmol). Following I/R injury, the response to SLIGRL was selectively preserved, whereas the dilator response to acetylcholine was converted to constriction. Trypsin also produced a vasodilator dose-response curve that was biphasic in nature (ED50-1=0.36 U, ED50-2=38.71 U). Desensitization of PAR2 receptors indicated that the high potency phase was mediated by PAR2. Removal of the endothelium but not treatment with L-NAME (300 μmol/L), indomethacin (5 μmol/L), or oxyhemoglobin (10 μmol/L) inhibited the response to SLIGRL and trypsin. Treatment with the K+-channel blockers TEA (10 mmol/L), charybdotoxin (20 nmol/L)/apamin (100 nmol/L), or elevated potassium (20 mmol/L) significantly suppressed responses. Similarly, inhibition of lipoxygenase with nordihydroguaiaretic acid (1 μmol/L), eicosatetraynoic acid (1 μmol/L), or baicalein (10 μmol/L), desensitization of C-fibers using capsaicin (1 μmol/L, 20 minutes), or blockade of vanilloid (VR1) receptors using capsazepine (3 μmol/L) inhibited the responses. This study shows, for the first time, that PAR2 activation causes endothelium-dependent coronary vasodilation that is preserved after I/R injury and is not mediated by NO or prostanoids, but involves the release of an endothelium-derived hyperpolarizing factor (EDHF), possibly a lipoxygenase-derived eicosanoid, and activation of VR1 receptors on sensory C-fibers.Keywords
This publication has 38 references indexed in Scilit:
- Protease-activated receptors: sentries for inflammation?Trends in Pharmacological Sciences, 2000
- Inducible expression of the kinin B1 receptor in the endotoxemic heart: mechanisms of des‐Arg9bradykinin‐induced coronary vasodilationBritish Journal of Pharmacology, 1999
- Characterization of the inflammatory response to proteinase‐activated receptor‐2 (PAR2)‐activating peptides in the rat pawBritish Journal of Pharmacology, 1999
- Endothelium‐derived relaxing, contracting and hyperpolarizing factors of mesenteric arteries of hypertensive and normotensive ratsBritish Journal of Pharmacology, 1999
- Increased vascular permeability by a specific agonist of protease‐activated receptor‐2 in rat hindpawBritish Journal of Pharmacology, 1998
- Dual endothelium‐dependent vascular activities of proteinase‐activated receptor‐2‐activating peptides: evidence for receptor heterogeneityBritish Journal of Pharmacology, 1998
- Perfusion-induced changes in cardiac contractility and oxygen consumption are not endothelium-dependentCardiovascular Research, 1997
- The Importance of the Hyperpolarizing Mechanism Increases as the Vessel Size Decreases in Endothelium-Dependent Relaxations in Rat Mesenteric CirculationJournal of Cardiovascular Pharmacology, 1996
- The Proteinase-activated Receptor 2 Is Induced by Inflammatory Mediators in Human Endothelial CellsJournal of Biological Chemistry, 1996
- Reperfusion after acute coronary occlusion in dogs impairs endothelium-dependent relaxation to acetylcholine and augments contractile reactivity in vitro.Journal of Clinical Investigation, 1987